PMID- 23342481
OWN - NLM
STAT- MEDLINE
DCOM- 20130212
LR  - 20130123
IS  - 0012-7183 (Print)
IS  - 0012-7183 (Linking)
VI  - 128
IP  - 22
DP  - 2012
TI  - [Multiple endocrine neoplasia type 1].
PG  - 2345-54
AB  - Multiple endocrine neoplasia type 1 (MEN1) is a complex multisystem disease 
      characterized by the combined occurrence of endocrine tumours of the parathyroid 
      glands, anterior pituitary gland and adrenal glands and the neuroendocrine 
      tumours (NET) of duodenum, pancreas, thymus and bronchus. Malignancy occurs 
      commonly (up to 30 %) and malignant NETs are important causes of the MEN1-related 
      morbidity and mortality. Regular clinical, biochemical and radiologic screening 
      for the syndrome-related tumours are the basis of the life-long surveillance. 
      Early detection and adequate management of these tumours reduce risk of death and 
      morbidity.
FAU - Salmela, Pasi I
AU  - Salmela PI
AD  - OYS, medisiininen tulosalue, sisatautien ja keuhkosairauksien vastuualue.
LA  - fin
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Tyypin 1 multippeli endokriininen neoplasia eli MEN 1-oireyhtymi.
PL  - Finland
TA  - Duodecim
JT  - Duodecim; laaketieteellinen aikakauskirja
JID - 0373207
SB  - IM
MH  - Early Diagnosis
MH  - Humans
MH  - Multiple Endocrine Neoplasia Type 1/*diagnosis/mortality/pathology
EDAT- 2013/01/25 06:00
MHDA- 2013/02/13 06:00
CRDT- 2013/01/25 06:00
PHST- 2013/01/25 06:00 [entrez]
PHST- 2013/01/25 06:00 [pubmed]
PHST- 2013/02/13 06:00 [medline]
PST - ppublish
SO  - Duodecim. 2012;128(22):2345-54.